首页 | 本学科首页   官方微博 | 高级检索  
     


Predictive medicine: outcomes,challenges and opportunities in the Synergy-COPD project
Authors:Felip Miralles  David Gomez-Cabrero  Magí Lluch-Ariet  Jesper Tegnér  Marta Cascante  Josep Roca  Synergy-COPD consortium
Affiliation:1.Barcelona Digital Technology Centre,Barcelona,Spain;2.Unit of Computational Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet,Karolinska University Hospital,Stockholm,Sweden;3.IDIBAPS, Hospital Clínic. Departament de Medicina. Facultat de Medicina and Departament de Bioquimica i Biologia Molecular, Facultat de Biologia,Universitat de Barcelona,Barcelona,Spain;4.Departament de Bioquimica i Biologia Molecular i IBUB, Facultat de Biologia,Universitat de Barcelona,Barcelona,Spain;5.CIBERES. Centro de Investigación en Red de Enfermedades Respiratorias (CibeRes),Palma de Mallorca;6.Departament d'Enginyeria Telemàtica (ENTEL),Universitat Politècnica de Catalunya,Barcelona,Spain
Abstract:

Background

Chronic Obstructive Pulmonary Disease (COPD) is a major challenge for healthcare. Heterogeneities in clinical manifestations and in disease progression are relevant traits in COPD with impact on patient management and prognosis. It is hypothesized that COPD heterogeneity results from the interplay of mechanisms governing three conceptually different phenomena: 1) pulmonary disease, 2) systemic effects of COPD and 3) co-morbidity clustering.

Objectives

To assess the potential of systems medicine to better understand non-pulmonary determinants of COPD heterogeneity. To transfer acquired knowledge to healthcare enhancing subject-specific health risk assessment and stratification to improve management of chronic patients.

Method

Underlying mechanisms of skeletal muscle dysfunction and of co-morbidity clustering in COPD patients were explored with strategies combining deterministic modelling and network medicine analyses using the Biobridge dataset. An independent data driven analysis of co-morbidity clustering examining associated genes and pathways was done (ICD9-CM data from Medicare, 13 million people). A targeted network analysis using the two studies: skeletal muscle dysfunction and co-morbidity clustering explored shared pathways between them.

Results

(1) Evidence of abnormal regulation of pivotal skeletal muscle biological pathways and increased risk for co-morbidity clustering was observed in COPD; (2) shared abnormal pathway regulation between skeletal muscle dysfunction and co-morbidity clustering; and, (3) technological achievements of the projects were: (i) COPD Knowledge Base; (ii) novel modelling approaches; (iii) Simulation Environment; and, (iv) three layers of Clinical Decision Support Systems.

Conclusions

The project demonstrated the high potential of a systems medicine approach to address COPD heterogeneity. Limiting factors for the project development were identified. They were relevant to shape strategies fostering 4P Medicine for chronic patients. The concept of Digital Health Framework and the proposed roadmap for its deployment constituted relevant project outcomes.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号